91 related articles for article (PubMed ID: 27377140)
1. Satellitosis and CD117 immunohistochemical expression correlates with poor outcome in thick vulvar melanoma.
Salcedo-Hernandez RA; Lino-Silva LS; Isla-Ortiz D; Posada-Torres JA; Chanona-Vilchis JG; Perez-Montiel MD; Aguilar-Romero JM; Dominguez-Rodriguez JA; Herrera-Gomez A
G Ital Dermatol Venereol; 2017 Feb; 152(1):8-12. PubMed ID: 27377140
[TBL] [Abstract][Full Text] [Related]
2. A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.
Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP
Int J Mol Med; 2014 Apr; 33(4):784-94. PubMed ID: 24535703
[TBL] [Abstract][Full Text] [Related]
3. KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
Dias-Santagata D; Selim MA; Su Y; Peng Y; Vollmer R; Chłopik A; Tell-Marti G; Paral KM; Shalin SC; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Br J Dermatol; 2017 Nov; 177(5):1376-1384. PubMed ID: 28734009
[TBL] [Abstract][Full Text] [Related]
4. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.
Seifried S; Haydu LE; Quinn MJ; Scolyer RA; Stretch JR; Thompson JF
Ann Surg Oncol; 2015; 22(6):1959-66. PubMed ID: 25384702
[TBL] [Abstract][Full Text] [Related]
5. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
[TBL] [Abstract][Full Text] [Related]
6. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
Verschraegen CF; Benjapibal M; Supakarapongkul W; Levy LB; Ross M; Atkinson EN; Bodurka-Bevers D; Kavanagh JJ; Kudelka AP; Legha SS
Int J Gynecol Cancer; 2001; 11(5):359-64. PubMed ID: 11737466
[TBL] [Abstract][Full Text] [Related]
7. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2014; 22(2):142-5. PubMed ID: 23958542
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome.
Gonzalez RS; Carlson G; Page AJ; Cohen C
Am J Clin Pathol; 2011 Jul; 136(1):74-80. PubMed ID: 21685034
[TBL] [Abstract][Full Text] [Related]
9. KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.
Janku F; Novotny J; Julis I; Julisova I; Pecen L; Tomancova V; Kocmanova G; Krasna L; Krajsova I; Stork J; Petruzelka L
Melanoma Res; 2005 Aug; 15(4):251-6. PubMed ID: 16034302
[TBL] [Abstract][Full Text] [Related]
10. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma of the vulva: a clinicopathological study of 50 women.
Bradgate MG; Rollason TP; McConkey CC; Powell J
Br J Obstet Gynaecol; 1990 Feb; 97(2):124-33. PubMed ID: 2317465
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma of the vulva: an extension of cutaneous melanoma?
Moxley KM; Fader AN; Rose PG; Case AS; Mutch DG; Berry E; Schink JC; Kim CH; Chi DS; Moore KN
Gynecol Oncol; 2011 Sep; 122(3):612-7. PubMed ID: 21570710
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.
de Melo Maia B; Lavorato-Rocha AM; Rodrigues IS; Baiocchi G; Cestari FM; Stiepcich MM; Chinen LT; Carvalho KC; Soares FA; Rocha RM
J Transl Med; 2012 Jul; 10():150. PubMed ID: 22839358
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma of the vulva.
Bastable JH; Gompel C; Verhest A
Diagn Gynecol Obstet; 1980; 2(1):55-62. PubMed ID: 7472144
[TBL] [Abstract][Full Text] [Related]
15. Vulvar melanoma: a 33 years single Italian center experience.
Catalano C; De Magnis A; Kanninen T; Sisti G; Sisti A; Sorbi F; Turrini I; Pimpinelli N; Fambrini M
G Ital Dermatol Venereol; 2015 Jun; 150(3):277-82. PubMed ID: 25236321
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma of the vulva: a clinical-pathologic review of 16 cases.
Benda JA; Platz CE; Anderson B
Int J Gynecol Pathol; 1986; 5(3):202-16. PubMed ID: 3759321
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
[TBL] [Abstract][Full Text] [Related]
18. [Vulvar melanoma].
Chokoeva A; Tchernev G; Wollina U
Akush Ginekol (Sofiia); 2015; 54(2):56-60. PubMed ID: 25909143
[TBL] [Abstract][Full Text] [Related]
19. c-kit expression in adenoid cystic carcinoma does not have an impact on local or distant tumor recurrence.
Aslan DL; Oprea GM; Jagush SM; Gulbahce HE; Adams GL; Gaffney PM; Savik K; Pambuccian SE
Head Neck; 2005 Dec; 27(12):1028-34. PubMed ID: 16240323
[TBL] [Abstract][Full Text] [Related]
20. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
